MBT-2 In Vitro Post-translational Modifications Assay
CAT#: ITS-1022-YF3454
Target Cell Organism: Mouse
Target Cell Name: MBT-2
Assay Type: Gene and Protein Expression Assays
Assay Overview
This assay is to provide MBT-2-based In Vitro Post-translational Modifications Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
MBT-2
Target Cell Organism
Mouse
Target Cell Background
MBT-2 cells are murine bladder cancer cells with epithelial characteristics. Their formation is induced by the administration of FANFT (N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide) to C3H/He mice.
Related Diseases
Bladder Cancer
Research Area
Oncology
Assay Name
In Vitro Post-translational Modifications Assay
Short Description
MBT-2-cell based In Vitro Post-translational Modifications Assay
Assay Description
Immunoassays and mass spectrometry techniques are considered ideal techniques for the detection of post-translational modification. Both the genetic and epigenetic modifications have contributed to the initiation and progression of cancer.
Assay Type
Gene and Protein Expression Assays
Assay Type Details
Following transcription, primary transcript RNA is converted into mature RNA by post-transcriptional modifications. Post-transcriptional modification includes three major steps namely the addition of a 5'cap, addition of a 3'polyadenylation tail and RNA splicing. Stability of RNA has been considered as very important for gene expression and proteins at the post-transcriptional level.